Biochemical Assays Drugs Regulations 
Chemical Biology and Drug Design
FEBRUARY 3, 2025
The invitro biochemical assays validated that J1-65 inhibits PTP-PEST activity competitively and the inhibitor binding stabilizes the protein-ligand complex. ABSTRACT PTP-PEST (also known as PTPN12) regulates cellular signaling and transduction pathways by dephosphorylating its substrate.
ASPET
DECEMBER 21, 2023
The incidence of ILDs associated with exposure to multiple hazards, such as inhaled particles, fibers, and ingested soluble chemicals, is increasing yearly, and there are no ideal drugs currently available. Further study revealed that DR3penA may mitigate pulmonary fibrosis by negatively regulating the PI3K/AKT pathway and MAPK pathway.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Agency IQ
JUNE 26, 2023
In effect, CDx are IVDs (and therefore medical devices) that are specifically intended for use with an accompanying drug or biological product and specifically when the IVD is “essential” for safe and effective use of that drug. But not all tests and diagnostics used with a drug product are actually CDx.
Agency IQ
APRIL 12, 2024
BY RACHEL COE, MSC | APR 11, 2024 1:06 PM CDT Regulatory background: Product potency and assays As defined in statute , the FDA uses the term “potency” to refer to the “specific ability or capability” of a product to “effect a given result.” morphological cell changes or alterations in protein production or expression).
Drug Target Review
JANUARY 5, 2024
fowleri cases 3 suggest that combinations of antibiotic and antifungal drugs, including azithromycin, amphotericin B, fluconazole, rifampin and miltefosine (the latter originally formulated for leishmaniasis and cancer chemotherapy 4 ), have a minimal impact on survival. The activity of Z#1334 in inhibiting Nf Ga7 GTPase assay (IC 50 of 2.4
Expert insights. Personalized for you.
100 
Let's personalize your content